Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke

Pharmacological agents limiting secondary tissue loss and improving functional outcomes after stroke are still limited. Cannabidiol (CBD), the major non-psychoactive component of Cannabis sativa, has been proposed as a neuroprotective agent against experimental cerebral ischemia. The effects of CBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Erika, Rieder, Phillip, Gobbo, Davide, Candido, Gabriella, Scheller, Anja, de Oliveira, Rúbia Maria Weffort, Kirchhoff, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659180/
https://www.ncbi.nlm.nih.gov/pubmed/36361675
http://dx.doi.org/10.3390/ijms232112886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659180/
https://www.ncbi.nlm.nih.gov/pubmed/36361675
http://dx.doi.org/10.3390/ijms232112886

Ejemplares similares